Interview: Pedro Moura – Managing Director, Merck Portugal
Pedro Moura is the first Portuguese managing director of Merck in Portugal, taking on the role in September 2017 after a stint in HQ in Darmstadt, Germany. Moura discusses Merck’s…
World Courier is the leader in specialty logistics for global clinical trials delivering fully-integrated GxP-compliant temperature-controlled transport, storage and distribution solutions worldwide with 140 + Offices in more than 50 countries.
Products and services
World Courier delivers its specialized logistics services across the full “life cycle” of the clinical trial process, beginning with pre-trial coordination with biopharmaceutical companies, CTSs, CROs and Central Labs. The company then manages the logistics and transport of all trial materials, packaging, scheduling and routing. Once a trial is underway, World Courier assists with regulatory and permit issues and manages the import of bulk drugs and supplies and offers strategically located centralized storage depots. We can also handle the intra-country distribution from investigational drug storage depots to clinical trial research sites, coordinate patient sample logistics, and manage drug return and destruction procedures.
Address
Polo Tecnológico de Lisboa
Rua Carlos Alves, nº 3 – 1ºEsq. e R/C
Tel: +35 1 218 411 120
Pedro Moura is the first Portuguese managing director of Merck in Portugal, taking on the role in September 2017 after a stint in HQ in Darmstadt, Germany. Moura discusses Merck’s…
Enrique Santos, president of the Spanish Chamber of Commerce in Portugal since 1998, observes the rapid change in the volume and nature of investments into Portugal in recent years. Santos…
Azevedos is one of the oldest pharmaceutical brands in Portugal. Lead by Thebar Miranda, president for 30 years it operates across Portuguese speaking companies and distributes worldwide. In this interview,…
Florian Ibe, managing director at Bayer Portugal, discusses market access hurdles, as well as Portugal’s expertise in scientific and clinical research and highly educated workforce. In three years of his…
Paulo Lilaia, president of the board of APOGEN and CEO of Generis, highlights the need for generics in the healthcare system and the government’s approach to their implementation. He also…
The Portuguese secretary of state for industry invites readers to discover the vibrant tech landscape in Portugal. Ana Teresa Lehmann unravels the reasons why Portugal is such an exciting investment…
Filipa Costa returned to Portugal in September 2016 to take on the leadership of the fastest growing multinational affiliate in the country – Janssen. In this interview, she reveals her…
Heitor Costa, Executive Director for APIFARMA, the Portuguese Pharmaceutical Industry Association, outlines the recent improvements in industry and governmental agreements, the importance of non-prescription medicines, and raising societal awareness on…
A new regulation is helping Portugal’s market access conditions for pharmaceuticals catch up with those of other developed European markets, with a jump in the number of approvals for 2017.…
Graca Didier, secretary general of AmCham Portugal, discuss the role of her chamber of commerce in promoting strong relations between America and Portugal. In addition, she comments on the cultural…
Joaquim Cunha, executive director of Health Cluster Portugal – a private, non-profit organisation dedicated to the consolidation of Portugal’s healthcare industry – discusses the up and coming changes to the…
Oscar Gaspar, VP of the Confederation of Portuguese Industry (CIP), president of the Portuguese Association of Private Hospitalization and former secretary of state for health (2009-2011), provides an informative insight…
See our Cookie Privacy Policy Here